Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.35 | N/A | -4.98% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-1.35 | N/A | -4.98% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current market conditions. They are committed to navigating these challenges while focusing on future growth.
Management acknowledged the challenges faced in the quarter.
They emphasized a focus on long-term strategies despite current setbacks.
Ultragenyx's earnings report showed a loss that was slightly worse than expected, but the stock reacted positively, rising 1.9%. This may indicate that investors are optimistic about the company's long-term potential despite the current losses. The lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ON SEMICONDUCTOR COR